OMI240920C17000
- 0.08
- +0.03+60.00%
Owens & Minor Newsroom
Express News | Owens & Minor Announces New Partnership With Google Cloud
Owens & Minor to Present at the 2024 Baird Global Healthcare Conference
BofA's Global Contenders and Defenders List
Express News | JP Morgan Maintains Underweight on Owens & Minor, Lowers Price Target to $18
Express News | Owens & Minor Inc : JP Morgan Cuts Target Price to $18 From $22
Owens & Minor, Inc.'s (NYSE:OMI) Shares Lagging The Industry But So Is The Business
Analysts Offer Insights on Healthcare Companies: Lexicon Pharmaceuticals (LXRX), Denali Therapeutics (DNLI) and Owens & Minor (OMI)
Analysts Have Conflicting Sentiments on These Healthcare Companies: Merus (MRUS), Twist Bioscience (TWST) and Owens & Minor (OMI)
Barclays Maintains Equal-Weight on Owens & Minor, Lowers Price Target to $18
Owens & Minor Analyst Ratings
Express News | Owens & Minor Inc : UBS Raises Target Price to $28 From $26
Barclays Maintains Owens & Minor(OMI.US) With Hold Rating, Maintains Target Price $18
Analysts Conflicted on These Healthcare Names: Owens & Minor (OMI), Tandem Diabetes Care (TNDM) and Alignment Healthcare (ALHC)
Owens & Minor Second Quarter 2024 Earnings: EPS Misses Expectations
Owens & Minor | 10-Q: Q2 2024 Earnings Report
Earnings Call Summary | Owens & Minor(OMI.US) Q2 2024 Earnings Conference
Express News | Owens & Minor Shares Are Trading Lower. The Company Reported Q2 Financial Results
Healthcare Logistics Provider Owens & Minor Calls Q2 Performance Consistent With Expectations, Reiterates Annual Guidance
Owens & Minor Releases Earnings Details on Website
Express News | Owens & Minor Reaffirms 2024 Guidance With Sales Of $10.5B-$10.9B And Adjusted EPS Of $1.40-$1.70, Versus Consensus Of $10.665B And $1.55, Respectively